Biometrics Built Better

Discover Veramed

Your guide to the industry and our role at 
its cutting edge.

Maintaining study integrity in complex data-sharing environments

A large pharmaceutical sponsor needed to manage complex unblinded data access during a highly complex Phase IIb study with multiple interim analyses.

Re-Randomization Tests in Clinical Trials: A Simulation Case Study & Practical Guidance

Learn how re-randomization tests can strengthen clinical trial analysis with a simulation case study and practical statistical guidance.

High pressure DMC delivery: Proactive planning to mitigate risk and ensure on-time outputs

Veramed provided independent unblinded statistical support for multiple DMC deliveries for a large pharma client’s Phase 2b double-blind,

Supporting sponsors through acquisitions: Skills to look for in your CRO

Acquisitions can create exciting opportunities for sponsors, but they also bring immediate pressure to understand the quality, readiness,

From oversight burden to operational efficiency: Rapid FSP deployment for a large pharma client

Through an FSP Team Model, Veramed developed a tailored partnership structure, plus efficient recruitment and onboarding process, to

Season 2 Episode 004 – The Human in the Loop: Matt Jones on AI at Veramed

In this podcast, we explore how artificial intelligence is reshaping clinical research - not as a replacement for

Reach Proof Faster: The Essential Guide for Early-Stage Biotechs

Discover how early-stage biotechs can reduce clinical trial costs, accelerate timelines, and choose the right biometrics partner to

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news straight to your inbox.